Systemic scleroderma

Feb 11, 2020

PRIVIGEN® (Immune Globulin Intravenous (Human), 10% Liquid) Granted Orphan-Drug Designation for the Investigational Treatment of Systemic Sclerosis (SSc)

Sep 09, 2019

FDA approves Ofev® as the first and only therapy to slow the rate of decline in pulmonary function in patients with systemic sclerosis-associated ILD

Sep 06, 2019

FDA approves first treatment for patients with rare type of lung disease

Mar 18, 2019

Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILD

Jan 09, 2019

New ELISA blood test from Gemelli Biotech offers important insights to patients with Scleroderma and Systemic Sclerosis

Nov 05, 2018

Global Scleroderma Market and Competitive Landscape Report 2018: Focus on US, Europe, Germany, France, Italy, Spain, UK & Japan

Sep 25, 2018

Raynaud's Association Launches New Campaign to Raise Awareness of Common, Painful Condition

Jul 26, 2018

12 Major Medical Research Centers Partner with the Scleroderma Research Foundation to "CONQUER" Scleroderma - an Often Lethal Autoimmune Disease

Mar 19, 2018

FDA grants Fast Track designation to nintedanib for the treatment of systemic sclerosis with associated interstitial lung disease

Feb 16, 2018

New initiative raises awareness of scleroderma through real-life stories of those living with the rare disease

Jun 07, 2017

Soin Neuroscience Files An Orphan Drug Application To Treat Systemic Sclerosis